Yahoo
NYSE - Delayed Quote USD

Healthpeak Properties, Inc. (DOC)

20.65 -0.38 (-1.81%)
At close: September 4 at 4:00:03 PM EDT
21.02 +0.37 (+1.79%)
After hours: September 4 at 7:59:40 PM EDT
Trade DOC on Coinbase
Dividend
DOC announced a cash dividend of $0.102 with an ex-date of Sep. 14, 2026
Chart Range Bar
Loading chart for DOC

What's happening with DOC?

52m ago
Powered by Yahoo Scout

Healthpeak Properties (DOC) recently reported strong Q2 results with adjusted FFO of $0.46 per share, surpassing estimates. The company raised its full-year FFO guidance to $1.73–$1.77, despite facing rising costs and a mixed outlook on dividends due to slow growth metrics.

Powered by Yahoo Scout
  • Previous Close 21.03
  • Open 20.94
  • Bid 20.73 x 280000
  • Ask 20.74 x 450000
  • Day's Range 20.62 - 21.15
  • 52 Week Range 15.70 - 22.95
  • Volume 3,054,089
  • Avg. Volume 5,956,447
  • Market Cap (intraday) 14.64B
  • Beta (5Y Monthly) 0.99
  • PE Ratio (TTM) 59.00
  • EPS (TTM) 0.35
  • Earnings Date Oct 22, 2026
  • Forward Dividend & Yield 1.22 (5.80%)
  • Ex-Dividend Date Sep 14, 2026
  • 1y Target Est 23.05

Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery. Healthpeak Properties, Inc. is based in Denver, Colorado. Healthpeak Properties, Inc. was incorporated in 1985 in Maryland.

www.healthpeak.com

411

Full Time Employees

December 31

Fiscal Year Ends

Real Estate

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 9/4/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

DOC
34.15%
S&P 500 (^GSPC)
12.75%

1-Year Return

DOC
22.64%
S&P 500 (^GSPC)
18.71%

3-Year Return

DOC
20.83%
S&P 500 (^GSPC)
70.93%

5-Year Return

DOC
24.86%
S&P 500 (^GSPC)
70.18%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue 771.58M
Earnings 52.82M
Profit Margin 6.85%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

0
200M
400M
600M
-10.0%
0.0%
10.0%
20.0%

Analyst Insights

View More

Analyst Price Targets

17.00 Low
23.05 Average
20.65 Current
29.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 8/31/2026
Analyst Barclays
Rating Action Maintains
Rating Equal-Weight
Price Action Raises
Price Target 23 -> 24

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (5yr expected)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.25%

  • Return on Assets (ttm)

    1.51%

  • Return on Equity (ttm)

    3.04%

  • Revenue (ttm)

    2.95B

  • Net Income Avi to Common (ttm)

    242.74M

  • Diluted EPS (ttm)

    0.35

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.64B

  • Total Debt/Equity (mrq)

    108.65%

  • Levered Free Cash Flow (ttm)

    1.65B

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: